Flortaucipir
- Generic Name
- Flortaucipir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H10FN3
- CAS Number
- 1415379-56-4
- Unique Ingredient Identifier
- J09QS3Z3WB
- Background
Flortaucipir is under investigation in clinical trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol).
- Associated Conditions
- -
- Associated Therapies
- -
NFL LONG Prospective Study
Phase 1
- Conditions
- Concussion, Brain
- Interventions
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 250
- Registration Number
- NCT04263337
- Locations
- 🇺🇸
Boston Children's Hospital, Waltham, Massachusetts, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath